Ftse Mib
34.239,80
-0,40%
DAX
18.526,25
-0,40%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,40%
Bitcoin
62.888,37
-3,03%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Applied Therapeutics Inc (APLT) Applied Therapeutics Inc (APLT) Notizie

APLT

Applied Therapeutics (APLT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:APLT
DataOraFonteTitoloSimboloCompagnia
14/05/202206:18TipRanksRobert W. Baird Thinks Applied Therapeutics’ Stock is Going to RecoverNASDAQ:APLTApplied Therapeutics Inc
12/05/202213:38Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APLTApplied Therapeutics Inc
12/05/202212:59GlobeNewswire Inc.Applied Therapeutics Reports First Quarter 2022 Financial ResultsNASDAQ:APLTApplied Therapeutics Inc
05/05/202213:30GlobeNewswire Inc.Applied Therapeutics to Present Data on AT-007 Treatment in SORD Deficiency at the 2022 Annual Meeting of the Peripheral Nerve SocietyNASDAQ:APLTApplied Therapeutics Inc
16/04/202201:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APLTApplied Therapeutics Inc
15/04/202213:08Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:APLTApplied Therapeutics Inc
15/04/202213:05Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:APLTApplied Therapeutics Inc
04/04/202213:30GlobeNewswire Inc.Applied Therapeutics to Present at the 43rd Annual Meeting of the Society for Inherited Metabolic DisordersNASDAQ:APLTApplied Therapeutics Inc
16/03/202212:30GlobeNewswire Inc.Applied Therapeutics to Present at the 2022 Annual Clinical Genetics Meeting of the American College of Molecular Genetics and GenomicsNASDAQ:APLTApplied Therapeutics Inc
12/03/202204:53TipRanksApplied Therapeutics (APLT) Gets a Buy Rating from Robert W. BairdNASDAQ:APLTApplied Therapeutics Inc
10/03/202215:49Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:APLTApplied Therapeutics Inc
10/03/202213:42Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APLTApplied Therapeutics Inc
10/03/202213:30GlobeNewswire Inc.Applied Therapeutics Reports Fourth Quarter and Year-end 2021 Financial ResultsNASDAQ:APLTApplied Therapeutics Inc
10/03/202212:33Edgar (US Regulatory)Annual Report (10-k)NASDAQ:APLTApplied Therapeutics Inc
01/03/202213:00GlobeNewswire Inc.Applied Therapeutics to Present at the Cowen and Barclays Investor ConferencesNASDAQ:APLTApplied Therapeutics Inc
28/02/202213:30GlobeNewswire Inc.Applied Therapeutics Supports 15th Annual Rare Disease DayNASDAQ:APLTApplied Therapeutics Inc
10/02/202213:00GlobeNewswire Inc.Applied Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare ConferenceNASDAQ:APLTApplied Therapeutics Inc
28/01/202222:34Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:APLTApplied Therapeutics Inc
26/01/202213:31Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:APLTApplied Therapeutics Inc
12/01/202200:44Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:APLTApplied Therapeutics Inc
05/01/202203:06TipRanksApplied Therapeutics (APLT) was Downgraded to a Hold Rating at BarclaysNASDAQ:APLTApplied Therapeutics Inc
03/01/202216:48Dow Jones NewsApplied Therapeutics Shares Slide on Lead Candidate DelayNASDAQ:APLTApplied Therapeutics Inc
03/01/202214:01Dow Jones NewsApplied Therapeutics Delays Plans to Seek FDA Approval of AT-007NASDAQ:APLTApplied Therapeutics Inc
03/01/202213:00GlobeNewswire Inc.Applied Therapeutics Provides Regulatory Update on Galactosemia ProgramNASDAQ:APLTApplied Therapeutics Inc
16/12/202113:00GlobeNewswire Inc.Applied Therapeutics Announces Initiation of Registrational Phase 2/3 Study of AT-007 in SORD DeficiencyNASDAQ:APLTApplied Therapeutics Inc
18/11/202113:00GlobeNewswire Inc.Applied Therapeutics to Present at the 14th International Congress of Inborn Errors of MetabolismNASDAQ:APLTApplied Therapeutics Inc
12/11/202113:00GlobeNewswire Inc.Applied Therapeutics Reports Third Quarter 2021 Financial ResultsNASDAQ:APLTApplied Therapeutics Inc
25/10/202113:00GlobeNewswire Inc.Applied Therapeutics Reports Biomarker Data from Pilot Trial of AT-007 in SORD DeficiencyNASDAQ:APLTApplied Therapeutics Inc
18/10/202113:00GlobeNewswire Inc.Applied Therapeutics Reports Additional Pediatric Biomarker Data from ACTION-Galactosemia KidsNASDAQ:APLTApplied Therapeutics Inc
09/09/202113:00GlobeNewswire Inc.Applied Therapeutics Reports Initial Pediatric Biomarker Data from ACTION-Galactosemia KidsNASDAQ:APLTApplied Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:APLT

La tua Cronologia

NASDAQ
VRDN
Viridian Therapeutics
NYSE
USPH
US Physical Therapy
BIT
P1WMA0
NLBNPIT1WMA0 20991231 1....
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network